Connect & Inspire

Share Your Story

Explore & Discover

Treatment & Care

Press Room

Subscribe

A Mom Continues Her Daughter’s Fight Against Cancer

After Vicki Bunke lost her 14-year-old daughter, Grace, to osteosarcoma, she started swimming across America to honor her legacy.

LATEST POSTS

Connect & Inspire

Stories of inspiration, community, and survival 

A Mom Continues Her Daughter’s Fight Against Cancer

A Mom Continues Her Daughter’s Fight Against Cancer

After Vicki Bunke lost her 14-year-old daughter, Grace, to osteosarcoma, she started swimming across America to honor her legacy.
An Osteosarcoma Diagnosis Benched This Teen Athlete — But Not for Long

An Osteosarcoma Diagnosis Benched This Teen Athlete — But Not for Long

Two surgeries, six rounds of chemo and countless nights in the hospital couldn’t stop Cheyenne from being a source of inspiration for those around her.
Osteosarcoma of the Jaw Survivor Savors the Simple, Small Things in Life

Osteosarcoma of the Jaw Survivor Savors the Simple, Small Things in Life

Diagnosed with a very rare type of bone cancer when her second daughter was a newborn, Nicole gained new perspective and appreciation for life. 

Share Your Story

Fill out the form below to tell us about yourself. Sharing stories of osteosarcoma families helps us raise awareness and funds for much-needed research.

Gavin, Osteosarcoma Patient 

Explore & Discover

Stories of research, progress and exploration

Osteosarcoma Discovered in a 77-Million-Year-Old Dinosaur Bone

Osteosarcoma Discovered in a 77-Million-Year-Old Dinosaur Bone

New research has led to the first diagnosis of advanced bone cancer in a dinosaur.
Meet Andrea Hayes, MD, OSI’s Strategic Advisory Board Member and Howard University’s First Female Chair of Surgery

Meet Andrea Hayes, MD, OSI’s Strategic Advisory Board Member and Howard University’s First Female Chair of Surgery

This world-renowned pediatric surgical oncologist is determined to change osteosarcoma outcomes.
OSI’s SIFT Committee: Facilitating Groundbreaking Research

OSI’s SIFT Committee: Facilitating Groundbreaking Research

The Strategic Initiatives Funding Team fosters an environment of collaboration and innovation by seeking researchers who can transform how we treat osteosarcoma.

Treatment and Care

OSI Connect: Connecting Experts with Osteosarcoma Patients and Their Families Around the World

OSI Connect: Connecting Experts with Osteosarcoma Patients and Their Families Around the World

The free, virtual platform provides access to expert physicians in the field of osteosarcoma who serve as reliable resources and support during a patient’s greatest time of need.
OSI’s Director Unveils 2021’s Grant Recipients

OSI’s Director Unveils 2021’s Grant Recipients

After receiving a record 26 proposals, Lee Helman, MD, shares the three winning projects the institute is funding in its quest improve treatment and, ultimately, eradicate osteosarcoma.

Press Room

OSI News & updates

A Phase II clinical trial funded by The Osteosarcoma Institute is now enrolling

This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment.

Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates

Novel approach paves the way for vast expansion in the number of drugs targeting osteosarcoma

The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma

The Osteosarcoma Institute (OSI) announced today that it has awarded a grant to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for a Phase II single arm study of olaparib (an FDA-approved PARP inhibitor) and ceralacertib/AZD6738 (an investigational ATR kinase inhibitor) in ...

Instagram

Before You Go

Sign-up for our newsletter and stay up-to-date about our fight against Osteosarcoma!

Translate »